1 – 20 of 32
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
(
- Contribution to journal › Article
- 2022
-
Mark
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes : Pooled Analysis of Population-Based Studies
(
- Contribution to journal › Article
- 2020
-
Mark
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
(
- Contribution to journal › Article
- 2018
-
Mark
Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings
(
- Contribution to journal › Article
-
Mark
A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk
2018) In Clinical cancer research : an official journal of the American Association for Cancer Research 24(23). p.5895-5901(
- Contribution to journal › Article
- 2017
-
Mark
Clinical management of pancreatic cancer aided by histone signatures
2017)(
- Thesis › Doctoral thesis (compilation)
- 2016
-
Mark
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
(
- Contribution to journal › Article
-
Mark
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera
(
- Contribution to journal › Article
-
Mark
The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies
(
- Contribution to journal › Article
- 2015
-
Mark
miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations
(
- Contribution to journal › Article
- 2014
-
Mark
Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
(
- Contribution to journal › Article
-
Mark
Efficient identification of miRNAs for classification of tumor origin
(
- Contribution to journal › Article
-
Mark
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Ferritin heavy chain in triple negative breast cancer : a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response
(
- Contribution to journal › Article
- 2013
-
Mark
Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer
(
- Contribution to journal › Article
-
Mark
Quantitative proteomic analysis of microdissected breast cancer tissues : comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches
(
- Contribution to journal › Article
- 2012
-
Mark
A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility
(
- Contribution to journal › Article
-
Mark
Global microRNA analysis of the NCI-60 cancer cell panel
(
- Contribution to journal › Article